Director of the Stanford Tissue Regeneration Laboratory
Associate Professor of Orthopaedic Surgery, Stanford University Medical Center
Jason L. Dragoo, MD is an Associate Professor of Orthopaedic Surgery at Stanford University. He specializes in Sports Medicine and currently serves as a team physician for numerous elite athletic associations including the US Ski Team, US Olympic Committee and Stanford University Athletics. He is currently the Head Team Physician for the Stanford Football Program and serves on the Board of Directors for the PAC 12 Conference Health and Wellness Committee. He is also active member of the AAOS Biologics Committee and the AOSSM Research Committee.
His basic science and clinical research has led to many advances in the use of biologics to augment tissue healing including:
- investigations on the formulations and applications platelet rich plasma (PRP) and autologous growth factors,
- cartilage regeneration using adult adipose-derived stem cells, and
- the development of 2nd generation methods, using autologous blood products, for tissue repair.
Dr. Dragoo currently has 5 active NIH grants, has published 3 textbooks, authored over 70 peer-reviewed articles and is the Director of the Stanford Tissue Regeneration Laboratory.
Recent Sessions at Neurovations Events
2017 Napa Pain Conference
- Evidence-based Regenerative Medicine Workshop
- Taylor, S. E., Lee, J., Smeriglio, P., Razzaque, A., Smith, R. L., Dragoo, J. L., … & Bhutani, N. (2016). Identification of human juvenile chondrocyte-specific factors that stimulate stem cell growth. Tissue Engineering Part A, 22(7-8), 645-653.
- Dragoo, Jason L. “The Use of Platelet-Rich and Platelet-Poor Plasma to Enhance Differentiation of Skeletal Myoblasts Implications for the Use of Autologous Blood Products for Muscle Regeneration.” Orthopaedic journal of sports medicine 4.7 suppl4 (2016): 2325967116S00150.
- LaPrade, R. F., Dragoo, J. L., Koh, J. L., Murray, I. R., Geeslin, A. G., & Chu, C. R. (2016). AAOS research symposium updates and consensus: biologic treatment of orthopaedic injuries. Journal of the American Academy of Orthopaedic Surgeons, 24(7), e62-e78.